MedTrace Logo

Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina

NCT04472078 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 873

Last updated 2020-12-17

No results posted yet for this study

Summary

Background The study aimed to establish the seroprevalence of SARS-COV-2 in an Argentinian slum three months after the first case was reported.

Methods Between June 10th and July 1st, a cross-sectional design was carried out on people over 14 years old, selected from a probabilistic sample of households. Finger prick puncture ELISA test

Conditions

Interventions

DIAGNOSTIC_TEST

Serological Assay or IgG for SARS-CoV-2

Serological Assay for detection of IgG for SARS-CoV-2

Sponsors & Collaborators

  • Hospital de Niños R. Gutierrez de Buenos Aires

    collaborator OTHER

  • Salud Comunitaria Ministerio de Salud GCBA

    collaborator UNKNOWN

  • Hospital Italiano de Buenos Aires

    lead OTHER

Principal Investigators

  • Alicia Mistchenko, MD PHD · Hospital de Niños Ricardo Gutierrez

  • Vanina L Pagotto, MD MG · Hospital Italiano de Buenos Aires

  • Silvana Figar, MD MG · Hospital Italiano de Buenos Aires

  • Andrea Gamarnik, PHD · National Council of Scientific and Technical Research, Argentina

  • Ana M Gomez Saldaño, MD MG · Salud Comunitaria Ministerio de Salud GCBA

  • Fernan Quiroz, MD MG · Ministerio de Salud GCBA

  • Lorena Luna, MG · Salud Comunitaria Ministerio de Salud GCBA

  • Magdalena Wagner Manslau · Salud Comunitaria Ministerio de Salud GCBA

  • Julieta Salto · Salud Comunitaria Ministerio de Salud GCBA

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-10
Primary Completion
2020-06-26
Completion
2020-12-11

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04472078 on ClinicalTrials.gov